Dynamics of allosteric modulation of lymphocyte function associated antigen-1 closure-open switch: unveiling the structural mechanisms associated with outside-in signaling activation

[1]  M. Sen,et al.  Leukocyte integrin alpha L beta 2 headpiece structures: The alpha I domain, the pocket for the internal ligand, and concerted movements of its loops. , 2016 .

[2]  T. Springer,et al.  Leukocyte integrin αLβ2 headpiece structures: The αI domain, the pocket for the internal ligand, and concerted movements of its loops , 2016, Proceedings of the National Academy of Sciences.

[3]  M. Soliman,et al.  Dual anti-inflammatory and selective inhibition mechanism of leukotriene A4 hydrolase/aminopeptidase: insights from comparative molecular dynamics and binding free energy analyses , 2016, Journal of biomolecular structure & dynamics.

[4]  M. Soliman,et al.  Flap flexibility amongst plasmepsins I, II, III, IV, and V: Sequence, structural, and molecular dynamics analyses , 2015, Proteins.

[5]  E. Seifert,et al.  OriginPro 9.1: Scientific Data Analysis and Graphing Software - Software Review , 2014, J. Chem. Inf. Model..

[6]  H. Oh,et al.  Inhibition of LFA-1/ICAM-1-mediated cell adhesion by stilbene derivatives from Rheum undulatum , 2012, Archives of Pharmacal Research.

[7]  Thean Chor Leow,et al.  The Role of Arg157Ser in Improving the Compactness and Stability of ARM Lipase , 2012 .

[8]  Alejandro Speck-Planche,et al.  Computer-aided drug design methodologies toward the design of anti-hepatitis C agents. , 2012, Current topics in medicinal chemistry.

[9]  Michael Loran Dustin,et al.  Integrin inside-out signaling and the immunological synapse. , 2012, Current opinion in cell biology.

[10]  Ning Li,et al.  Conformational Stability Analyses of Alpha Subunit I Domain of LFA-1 and Mac-1 , 2011, PloS one.

[11]  Marian Brennan,et al.  Integrins as therapeutic targets: lessons and opportunities , 2010, Nature Reviews Drug Discovery.

[12]  Rennian Wang,et al.  Integrins and extracellular matrices in pancreatic tissue engineering. , 2009, Frontiers in bioscience.

[13]  J. Barrish,et al.  Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold. , 2007, Bioorganic & medicinal chemistry letters.

[14]  P. M. Davis,et al.  Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1. , 2006, Journal of medicinal chemistry.

[15]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[16]  Ioan Andricioaei,et al.  Conversion between three conformational states of integrin I domains with a C-terminal pull spring studied with molecular dynamics. , 2004, Structure.

[17]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[18]  T. Ceska,et al.  Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry. , 2004, Biochemistry.

[19]  N. Hogg,et al.  T-cell integrins: more than just sticking points , 2003, Journal of Cell Science.

[20]  Junichi Takagi,et al.  Structures of the αL I Domain and Its Complex with ICAM-1 Reveal a Shape-Shifting Pathway for Integrin Regulation , 2003, Cell.

[21]  Timothy A. Springer,et al.  Reversibly locking a protein fold in an active conformation with a disulfide bond: Integrin αL I domains with high affinity and antagonist activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Junichi Takagi,et al.  Locking in alternate conformations of the integrin αLβ2 I domain with disulfide bonds reveals functional relationships among integrin domains , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Zimmerman,et al.  The Leukocyte Integrins* , 2000, The Journal of Biological Chemistry.

[24]  R. Kriwacki,et al.  Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain. , 1999, Journal of molecular biology.

[25]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[26]  M. Pfaff,et al.  Integrin affinity modulation. , 1998, Trends in cell biology.

[27]  D. Leahy,et al.  Crystal structure of the I-domain from the CD11a/CD18 (LFA-1, alpha L beta 2) integrin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  V. Moy,et al.  Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells. , 1993, The Journal of biological chemistry.

[29]  Anil Kumar,et al.  Role of Bioinformatics in Biotechnology , 2017 .

[30]  Vesna Erakovic Haber,et al.  Discovery and Development of Novel Drugs. , 2017, Progress in molecular and subcellular biology.

[31]  M. Shimaoka,et al.  Conformational regulation of integrin structure and function. , 2002, Annual review of biophysics and biomolecular structure.

[32]  R. Liddington,et al.  Structural basis of collagen recognition by integrin alpha2beta1. , 2000, Cell.

[33]  M. Auer,et al.  Identification and X-ray Co-crystal Structure of a Small-Molecule Activator of LFA-1-ICAM-1 Binding , 2014, Angewandte Chemie.